Pancreaticoduodenectomy in the Middle East: Achieving optimal results through specialization and standardization

dc.contributor.authorFaraj, Walid G.
dc.contributor.authorNassar, Hussein
dc.contributor.authorZaghal, Ahmad M.
dc.contributor.authorMukherji, Deborah M.
dc.contributor.authorShamseddine, Ali I.
dc.contributor.authorKanso, Mariam
dc.contributor.authorJaafar, Rola F.
dc.contributor.authorKhalife, Mohamad Jawad
dc.contributor.departmentSurgery
dc.contributor.departmentInternal Medicine
dc.contributor.departmentHepatopancreaticobiliary and Liver Transplantation Unit
dc.contributor.departmentDivision of Hematology Oncology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:12:59Z
dc.date.available2025-01-24T12:12:59Z
dc.date.issued2019
dc.description.abstractBackground: Pancreaticoduodenectomy is a challenging surgical intervention that remains the cornerstone in the treatment of localized peri‑ampullary pathologies. The concept of treatment standardization has been well-established in many high-volume centers in the world. Here, we present our experience in pancreaticoduodenectomy from 1994 to 2015. Methods: We performed a retrospective review of the medical charts of patients who underwent pancreaticoduodenectomy at our institution. Data was entered to SPSS statistical software and analyzed. The Mann–Whitney U and Fisher's exact tests were used to report statistical differences between groups. Results: Of the 370 patients who underwent pacreaticoduodenectomy, 300 were analyzed. The 1-, 3-, 5- and 10-year survival rates were 85%, 35%, 15%, and 7%, respectively with a 30-day mortality rate of 5.0% (15 patients). The median age of the patients was 61 (13–84) years, with 193 (64.3%) males and 107 (35.7%) females. The median operative time was 300 (130–570) min. The median postoperative length of hospital stay was 12 (5–76) days. Thirty-two patients required re-laparotomies; 10 for pancreatic leak, 7 for biliary leak and 15 for control of bleeding. Seventy-five (25.0%) patients developed pancreatic fistulae. Delayed gastric emptying was present in 31 (10.3%) patients. A significant improvement in surgical outcome was observed in cases done after 2008 which indicates the important role of specialized team in surgical management. Conclusions: The number of patients undergoing pancreaticoduodenectomy has been increasing annually over the past twenty-two years in our institution with results comparable to published series from high-volume centers. Through standardization of surgical techniques and perioperative management carried out by a specialist team, our results continue to improve despite the increasing complexity of cases referred to our unit. © 2019 First Affiliated Hospital, Zhejiang University School of Medicine in China
dc.identifier.doihttps://doi.org/10.1016/j.hbpd.2019.02.001
dc.identifier.eid2-s2.0-85062210382
dc.identifier.pmid30846244
dc.identifier.urihttp://hdl.handle.net/10938/32943
dc.language.isoen
dc.publisherElsevier (Singapore) Pte Ltd
dc.relation.ispartofHepatobiliary and Pancreatic Diseases International
dc.sourceScopus
dc.subjectMiddle east
dc.subjectPancreatic cancer
dc.subjectPancreaticoduodenectomy
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectAnastomosis, surgical
dc.subjectAnastomotic leak
dc.subjectBile ducts
dc.subjectClinical competence
dc.subjectDigestive system neoplasms
dc.subjectFemale
dc.subjectHumans
dc.subjectLength of stay
dc.subjectMale
dc.subjectMiddle aged
dc.subjectNeoplasm staging
dc.subjectOperative time
dc.subjectPancreatic ducts
dc.subjectPancreatic fistula
dc.subjectPostoperative hemorrhage
dc.subjectReference standards
dc.subjectReoperation
dc.subjectRetrospective studies
dc.subjectSpecialization
dc.subjectSurvival rate
dc.subjectYoung adult
dc.subjectLow molecular weight heparin
dc.subjectPiperacillin plus tazobactam
dc.subjectAbdominal abscess
dc.subjectAbdominal pain
dc.subjectAcute kidney failure
dc.subjectAcute pancreatitis
dc.subjectAntibiotic prophylaxis
dc.subjectArticle
dc.subjectBile leakage
dc.subjectBody mass
dc.subjectCancer survival
dc.subjectComorbidity
dc.subjectControlled study
dc.subjectCoronary artery disease
dc.subjectDeep vein thrombosis
dc.subjectDiabetes mellitus
dc.subjectEndoscopic retrograde cholangiopancreatography
dc.subjectGastrojejunostomy
dc.subjectHeart disease
dc.subjectHepatojejunostomy
dc.subjectHuman
dc.subjectHuman tissue
dc.subjectJaundice
dc.subjectLaparotomy
dc.subjectMajor clinical study
dc.subjectOperation duration
dc.subjectOutcome assessment
dc.subjectPancreas cancer
dc.subjectPancreas fistula
dc.subjectPneumonia
dc.subjectPostoperative complication
dc.subjectRetrospective study
dc.subjectSepsis
dc.subjectStomach paresis
dc.subjectSurgical infection
dc.subjectUrinary tract infection
dc.subjectVery elderly
dc.subjectAdverse event
dc.subjectAnastomosis
dc.subjectAnastomosis leakage
dc.subjectBile duct
dc.subjectCancer staging
dc.subjectDigestive system tumor
dc.subjectPancreatic duct
dc.subjectPathology
dc.subjectStandard
dc.titlePancreaticoduodenectomy in the Middle East: Achieving optimal results through specialization and standardization
dc.typeArticle

Files